Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Live Attenuated Vaccines Companies

Live attenuated vaccines companies specialize in the development of vaccines using weakened forms of infectious agents. These companies contribute to public health by creating vaccines that induce an immune response without causing the disease. Live attenuated vaccines are effective in preventing various viral infections, including measles, mumps, rubella, and influenza. Companies in this sector prioritize vaccine safety and efficacy to provide robust protection against infectious diseases.

Live Attenuated Vaccines Key Companies

Latest Live Attenuated Vaccines Companies Update:

Jan 2024 Merck & Co., Received FDA approval for their expanded label claim for Keytruda® (pembrolizumab) to include adjuvant treatment of stage III non-small cell lung cancer (NSCLC) following a complete resection, potentially complementing live attenuated vaccines by strengthening immune response against future viral infections. Partnered with vaccine manufacturers to advance vaccine research and development, particularly for COVID-19 booster shots and vaccines for emerging viral threats.

GlaxoSmithKline plc (GSK), Announced the start of Phase 3 clinical trials for a new shingles vaccine candidate, potentially adding to their existing Shingrix® vaccine and contributing to improved protection against shingles in older adults. Invested in research and development of live attenuated vaccines for rotavirus, RSV, and other pediatric diseases.

Sanofi S.A Achieved positive Phase 3 results for their dengue vaccine candidate, DengueTetra™, raising hopes for a safe and effective vaccine against all four serotypes of dengue virus. Focused on expanding their vaccine portfolio, including live attenuated vaccines for neglected tropical diseases like yellow fever and Japanese encephalitis.

Serum Institute of India Pvt. Ltd, Partnered with Gavi, the Vaccine Alliance, to supply affordable rotavirus vaccines for low- and middle-income countries, increasing access to live attenuated vaccines globally. Emphasized their commitment to manufacturing and supplying high-quality, affordable vaccines for various infectious diseases.

Takeda Pharmaceutical Company Limited Received WHO prequalification for TAKEDA RotaTeq™ rotavirus vaccine, making it readily available for routine immunization programs in developing countries. Collaborated with academic institutions to explore the potential of using live attenuated vaccines for treating chronic diseases like cancer and autoimmune disorders.

List of Live Attenuated Vaccines companies in the market

GlaxoSmithKline plc. (U.K.)

Merck & Co. (U.S.)

Pfizer Inc. (U.S.)

Astellas Pharma Inc. (Japan)

Johnson & Johnson (U.S.)

CSL Limited (Australia)

Emergent BioSolutions Inc. (U.S.)

MedImmune LLC (U.S.)

Sanofi (France)

Serum Institute of India Pvt. Ltd. (India)

Live Attenuated Vaccines Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.